SLC2A1 and neoplasm: In a recent study, another promising GLUT inhibitor named DRB18 (Figure 5B), which belongs to a synthetic small inhibitory molecule, has been reported with the ability for GLUT inhibition as evaluated on A549 tumor-bearing nude mice and HER293 cell lines (Shriwas et al., 2021).